CELG

Celgene Corporation News Headlines

$88.34
*  
0.61
0.7%
Get CELG Alerts
*Delayed - data as of Jul. 30, 2014  -  Find a broker to begin trading CELG now
Exchange: NASDAQ
Industry: Health Care
Community Rating:
View:    CELG Pre-Market
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save stocks for next time
Viewing
Filtered By
Ordered By

Data on PCYC's ibrutinib - Analyst Blog
6/20/2013 11:30:01 AM - Zacks.com

IPO Preview: Bluebird Bio
6/19/2013 5:33:00 AM - Seeking Alpha

An Interview With Elemer Piros: A Strong Year For Biotechs, Looking From The Halfway Point
6/18/2013 11:34:00 AM - Seeking Alpha

Good News for Celgene's Pipeline - Analyst Blog
6/18/2013 11:30:01 AM - Zacks.com

Good News for Celgene's Revlimid - Analyst Blog
6/17/2013 11:31:15 AM - Zacks.com

Data on BMY/ AbbVie's elotuzumab - Analyst Blog
6/17/2013 11:30:10 AM - Zacks.com

Apremilast Data Presented by Celgene - Analyst Blog
6/14/2013 11:30:14 AM - Zacks.com

Cramer's Mad Money - The Kids' Portfolio (6/13/13)
6/14/2013 4:28:00 AM - Seeking Alpha

Novartis: Drug Pipeline And New Drug Applications
6/13/2013 4:35:00 PM - Seeking Alpha

CELG Presents Positive Long-term Data - Analyst Blog
6/13/2013 4:31:02 PM - Zacks.com

Warning: This Might Be The Most Overvalued Sector In The Market
6/12/2013 8:47:00 PM - Seeking Alpha

Clovis / CO-1686: Value, Derived From Data, Supports The Valuation
6/12/2013 10:27:00 AM - Seeking Alpha

Clovis / CO-1686: Value, Derived From Data, Supports The Valuation
6/12/2013 8:54:28 AM - SeekingAlpha

When It Comes To Biotech, Diversity Is Key
6/12/2013 7:51:00 AM - Seeking Alpha

Celgene Moves Fast And Early In Expanding Its Pipeline
6/10/2013 1:45:00 PM - Seeking Alpha

Label Expanded for CELG's Revlimid - Analyst Blog
6/7/2013 12:30:32 PM - Zacks.com

Setback for Pluristem Therapeutics - Analyst Blog
6/5/2013 5:27:36 PM - Zacks.com

Celgene Presents Data at ASCO - Analyst Blog
6/5/2013 11:27:21 AM - Zacks.com

Rexahn's Oncology Platform Led By Its Akt-1 Inhibitor Challenges Big Pharma With Ground-Breaking Cancer Therapy
6/5/2013 5:53:00 AM - Seeking Alpha

Top Funds' New Buys Include Some Leading Stocks
6/4/2013 7:03:00 PM - Investor's Business Daily

Celgene Stock Still Has Plenty Of Room To Grow Due To A Strong Product Line
6/4/2013 2:46:00 PM - Seeking Alpha

CHMP Backs Celgene's Pomalyst - Analyst Blog
6/3/2013 7:27:44 PM - Zacks.com

As Pfizer Eyes It, Celgene Calls Cellceutix
5/31/2013 8:36:00 AM - Seeking Alpha

Gilead's Stribild Approved in the EU - Analyst Blog
5/29/2013 6:29:37 PM - Zacks.com

Encouraging Data from Alkermes - Analyst Blog
5/29/2013 5:27:08 PM - Zacks.com